{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:02:51Z","timestamp":1789448571691,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Negative histology (NH), defined as normal pituitary tissue without histopathological evidence of tumor despite clinical, biochemical and radiological or functional evidence of a pituitary neuroendocrine tumor (PitNET), is well described in Cushing\u2019s disease but poorly characterized in other subtypes. We assessed its prevalence, mechanisms, and clinical implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 651 patients who underwent transsphenoidal surgery for a PitNET (1996\u20132023). Epidemiological analyses included the entire cohort; clinical and prognostic analyses were restricted to microadenomas of the three main functional subtypes (ACTH, PRL, GH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      NH occurred in 28.1% of ACTH-, 28.1% of PRL-, and 11.4% of GH-secreting tumors, and was strongly associated with microadenomas. Baseline and hormonal characteristics were similar between NH and PH cases, except for lower IGF-1 levels in GH NH tumors. At 6 weeks, remission rates were lower in NH for ACTH (60% vs. 93.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.01) and PRL (50% vs. 79.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.03), but similar in GH. In ACTH tumors, mislocalization accounted for 66.7% of unfavorable NH outcomes and may explain the excess of failures versus PH cases. Mislocalization was rare (6.7%) in PRL tumors and not reported in GH tumors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NH is heterogeneous, arising from three mechanisms whose contributions vary by subtype. In ACTH tumors, mislocalization predominates and is associated with lower early remission. In PRL tumors, mislocalization is uncommon but may contribute to lower early remission. In GH tumors, NH likely reflects technical or histological limitations and carries a favorable prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1933467","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:26:35Z","timestamp":1789446395000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical relevance of negative histology after transsphenoidal surgery for pituitary neuroendocrine tumors"],"prefix":"10.3389","volume":"17","author":[{"given":"Gilles","family":"De Canni\u00e8re","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Universit\u00e9 Catholique de Louvain","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Raftopoulos","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saint-Luc University Hospital","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Clinique Notre-Dame de Grace (CNDG)","place":["Gosselies, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"de Nijs","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saint-Luc University Hospital","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Daoud","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saint-Luc University Hospital","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan Matei","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e9 Catholique de Louvain","place":["Brussels, Belgium"]},{"name":"Department of Endocrinology and Nutrition, Saint-Luc University Hospital","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsalia","family":"Alexopoulou","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e9 Catholique de Louvain","place":["Brussels, Belgium"]},{"name":"Department of Endocrinology and Nutrition, Saint-Luc University Hospital","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Fomekong","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e9 Catholique de Louvain","place":["Brussels, Belgium"]},{"name":"Department of Neurosurgery, Saint-Luc University Hospital","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0838-2","article-title":"Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement","volume":"20","author":"Casanueva","year":"2017","journal-title":"Pituitary"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5444","article-title":"Diagnosis and management of pituitary adenomas: A review","volume":"329","author":"Tritos","year":"2023","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1400043","article-title":"Trans-sphenoidal surgery for microprolactinoma: An acceptable alternative to dopamine agonists","volume":"140","author":"Turner","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.7.8645","article-title":"Surgical treatment of prolactin-secreting pituitary adenomas: Early results and long-term outcome","volume":"87","author":"Losa","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00005792-199907000-00004","article-title":"Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses: Retrospective analysis of 353 patients","volume":"78","author":"Gsponer","year":"1999","journal-title":"Medicine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.9.7819","article-title":"Surgical management of GH-secreting pituitary adenomas: An outcome study using modern remission criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0208","article-title":"Outcomes and management of patients with Cushing\u2019s disease without pathological confirmation of tumor resection after transsphenoidal surgery","volume":"92","author":"Pouratian","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2015.04.059","article-title":"Primary endoscopic transnasal transsphenoidal surgery for magnetic resonance image\u2013positive Cushing disease: Outcomes of a series over 14 years","volume":"84","author":"Kuo","year":"2015","journal-title":"World Neurosurg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"150017","DOI":"10.1530\/EDM-15-0017","article-title":"Pituitary hyperplasia: Case series and literature review of an under-recognised and heterogeneous condition","volume":"2015","author":"De Sousa","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3171\/2020.9.jns201514a","article-title":"Corticotroph hyperplasia and Cushing disease: Diagnostic features and surgical management","volume":"135","author":"Catalino","year":"2020","journal-title":"J Neurosurg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.02.002","article-title":"Prognostic factors of long-term remission after surgical treatment of Cushing\u2019s disease","volume":"47","author":"Ioachimescu","year":"2018","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11102-020-01066-8","article-title":"Outcomes of pituitary surgery for Cushing\u2019s disease: A systematic review and meta-analysis","volume":"23","author":"Stroud","year":"2020","journal-title":"Pituitary"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-6-487","article-title":"Transsphenoidal microsurgery for Cushing disease","volume":"109","author":"Mampalam","year":"1988","journal-title":"Ann Intern Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb03890.x","article-title":"Transsphenoidal surgery for Cushing\u2019s disease: Does what is removed determine the endocrine outcome","volume":"33","author":"Burke","year":"1990","journal-title":"Clin Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02141.x","article-title":"High prolactin levels in patients with Cushing\u2019s disease without pathological evidence of pituitary adenoma","volume":"38","author":"Comtois","year":"1993","journal-title":"Clin Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2265.1993.tb00976.x","article-title":"Assessment of endocrine function after transsphenoidal surgery for Cushing\u2019s disease","volume":"38","author":"McCance","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00701-015-2638-7","article-title":"Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: Outcomes with Cushing\u2019s disease","volume":"158","author":"Sarkar","year":"2016","journal-title":"Acta Neurochir"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.07.055","article-title":"Outcome of transsphenoidal surgery for Cushing disease: A single-center experience over 20 years","volume":"119","author":"Brichard","year":"2018","journal-title":"World Neurosurg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2022-0088","article-title":"Bilateral inferior petrosal sinus sampling in the diagnosis of ACTH-dependent Cushing\u2019s syndrome: Experience in a tertiary hospital","volume":"3","author":"Moreno Parro","year":"2022","journal-title":"Adv Lab Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05299","article-title":"Lateralization of inferior petrosal sinus sampling in Cushing\u2019s disease correlates with cavernous sinus venous drainage patterns, but not tumor lateralization","volume":"6","author":"Ghorbani","year":"2020","journal-title":"Heliyon"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3943","article-title":"The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing\u2019s disease","volume":"98","author":"Wind","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1230447","article-title":"Emerging diagnostic methods and imaging modalities in Cushing\u2019s syndrome","volume":"14","author":"Wright","year":"2023","journal-title":"Front Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf047","article-title":"Diagnostic value of 11C-methionine PET-CT imaging in persistent or recurrent Cushing disease after surgery","volume":"110","author":"Furnica","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009952930425","article-title":"Pituitary hyperplasia","volume":"1","author":"Horvath","year":"1999","journal-title":"Pituitary"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1227\/01.neu.0000313117.35824.9f","article-title":"Outcomes after repeat transsphenoidal surgery for recurrent Cushing\u2019s disease","volume":"63","author":"Patil","year":"2008","journal-title":"Neurosurgery"},{"key":"B27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1227\/NEU.0b013e31822dda2c","article-title":"Transsphenoidal surgery for Cushing disease: Experience with 136 patients","volume":"70","author":"Ciric","year":"2012","journal-title":"Neurosurgery"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2008.12.011","article-title":"Outcome of transsphenoidal surgery for Cushing\u2019s disease: A high remission rate in ACTH-secreting macroadenomas","volume":"111","author":"Fomekong","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02133","article-title":"Transsphenoidal pituitary surgery via the endoscopic technique: Results in 35 consecutive patients with Cushing\u2019s disease","volume":"154","author":"Netea-Maier","year":"2006","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1933467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:26:36Z","timestamp":1789446396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1933467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":29,"alternative-id":["10.3389\/fendo.2026.1933467"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1933467","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1933467"}}